Official title: Prospective, Multi-Center Study Using Bearing nsPVA Embolization Particles for the Treatment of uTErine fibRoids With Uterine Artery Embolization Summary: This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months. Conditions: Uterine Fibroid Study type: OBSERVATIONAL Enrollment: 100 (ESTIMATED) Status: RECRUITING Completion: 2026-12 (ESTIMATED)
ClinicalTrials.gov published a clinical update in Oncology on 01 Apr 2026.
The item focuses on Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE).
Review the original article for the full source wording and details.